Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Use of CereGate Therapy for Freezing of Gait in PD

NCT: NCT05292794 · RECRUITING

NCT IDNCT05292794

StatusRECRUITING

Start Date2022-04-18

SponsorCereGate Inc. (INDUSTRY)

First posted2022-03-23

Last updated2026-05-28

Brief Summary

A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑